Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance.


Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
09 2020
Historique:
pubmed: 18 9 2018
medline: 20 11 2021
entrez: 18 9 2018
Statut: ppublish

Résumé

Several concepts, which in the aggregate get might be used to account for "resilience" against age- and disease-related changes, have been the subject of much research. These include brain reserve, cognitive reserve, and brain maintenance. However, different investigators have use these terms in different ways, and there has never been an attempt to arrive at consensus on the definition of these concepts. Furthermore, there has been confusion regarding the measurement of these constructs and the appropriate ways to apply them to research. Therefore the reserve, resilience, and protective factors professional interest area, established under the auspices of the Alzheimer's Association, established a whitepaper workgroup to develop consensus definitions for cognitive reserve, brain reserve, and brain maintenance. The workgroup also evaluated measures that have been used to implement these concepts in research settings and developed guidelines for research that explores or utilizes these concepts. The workgroup hopes that this whitepaper will form a reference point for researchers in this area and facilitate research by supplying a common language.

Identifiants

pubmed: 30222945
pii: S1552-5260(18)33491-5
doi: 10.1016/j.jalz.2018.07.219
pmc: PMC6417987
mid: NIHMS1504388
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1305-1311

Subventions

Organisme : NIA NIH HHS
ID : P30 AG062715
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG016714
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG008702
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066462
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG026158
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG022381
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG050595
Pays : United States

Informations de copyright

© 2019 the Alzheimer's Association.

Auteurs

Yaakov Stern (Y)

Cognitive Neuroscience Division, Department of Neurology, Columbia University, New York, NY, USA.

Eider M Arenaza-Urquijo (EM)

Mayo Clinic, Rochester, MN, USA.

David Bartrés-Faz (D)

Faculty of Medicine and Health Sciences, Department of Medicine, Barcelona, Spain.
Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Sylvie Belleville (S)

Research Center of the Institut Universitaire de gériatrie de Montréal and Université de Montréal, Montreal, Canada.

Marc Cantilon (M)

Department of Psychiatry, RWJ Medical School, New Brunswick, NJ, USA.

Gael Chetelat (G)

Inserm, Inserm UMR-S U1237, Université de Caen-Normandie, GIP Cyceron, Caen, France.

Michael Ewers (M)

Institute for Stroke and Dementia Research (ISD), Klinikum der Universität München, Ludwig Maximilian University LMU, Munich, Germany.

Nicolai Franzmeier (N)

Institute for Stroke and Dementia Research (ISD), Klinikum der Universität München, Ludwig Maximilian University LMU, Munich, Germany.

Gerd Kempermann (G)

German Center for Neurodegenerative Diseases (DZNE) Dresden, and CRTD - Center for Regenerative Therapies Dresden, Technische Universität Dresden, Dresden, Germany.

William S Kremen (WS)

Department of Psychiatry and Center for Behavior Genetics of Aging, University of California, San Diego, La Jolla, CA, USA.

Ozioma Okonkwo (O)

University of Wisconsin-Madison, Madison, WI, USA.

Nikolaos Scarmeas (N)

Department of Social Medicine, Psychiatry and Neurology, National and Kapodistrian University of Athens, Greece.
Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Gertrude H. Sergievsky Center, Department of Neurology, Columbia University, New York, NY, USA.

Anja Soldan (A)

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Chinedu Udeh-Momoh (C)

Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, UK.

Michael Valenzuela (M)

Brain & Mind Centre and Sydney Medical School, The University of Sydney, Sydney, Australia.

Prashanthi Vemuri (P)

Mayo Clinic Rochester, Rochester, MN, USA.

Eero Vuoksimaa (E)

Institute for Molecular Medicine Finland, University of Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH